Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576042 · ClinicalTrials.gov registry record · NA
Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01576042 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 27 participants.
The verdict
NCT01576042, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this pilot trial is to determine the feasibility of a large, multi-center randomized clinical trial aimed to test whether a treatment strategy of percutaneous catheter ablation of ventricular tachycardia (VT) is superior to state-of-the-art pharmacologic therapy at reducing all-cause mortality in patients with an implantable cardioverter defibrillator (ICD) who receive therapy for VT in the absence of any reversible cause.
Interventions
- DRUG amiodarone
- DRUG sotalol
- DEVICE Biosense Webster's NAVI-STAR Thermo-Cool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576042
The ClinicalTrials.gov registry entry for NCT01576042 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which amiodarone is the first listed.
NCT01576042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576042 about?
NCT01576042 is a clinical study titled "Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator". The purpose of this pilot trial is to determine the feasibility of a large, multi-center randomized clinical trial aimed to test whether a treatment strategy of percutaneous catheter ablation of ventricular tachycardia (VT) is superior to state-of-the-art pharmacologic therapy at reducing all-cause ...
What is the current status of trial NCT01576042?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2012-05. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01576042?
The interventions under investigation include: amiodarone (DRUG), sotalol (DRUG), Biosense Webster's NAVI-STAR Thermo-Cool (DEVICE).
Who is sponsoring clinical trial NCT01576042?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.